Custom GalNAc peptide conjugation services for ASGPR liver targeting, hepatocyte uptake studies, and peptide targeting ligand research (project-dependent).
GalNAc–peptide conjugates are non-drug peptide–ligand conjugates where peptides are covalently linked to N-acetylgalactosamine (GalNAc) motifs as a form of peptide–targeting ligand conjugation to support ASGPR-mediated recognition and uptake in hepatocyte-focused research. Triantennary formats (often called Tri-GalNAc) present multiple GalNAc units to enhance receptor engagement via multivalent binding concepts. [1], [2]
While Tri-GalNAc technology is best known from liver-targeted oligonucleotide delivery, the underlying ASGPR recognition principles are often used more broadly for ligand presentation and cellular uptake studies. In peptide conjugation, attachment site and spacer/PEG selection are typically chosen to preserve peptide function while presenting the GalNAc cluster in an accessible geometry (project-dependent). [2], [3]
Bio-Synthesis builds chemically defined Tri-GalNAc peptide conjugates by attaching a triantennary GalNAc ligand cluster to a selected peptide site—such as the N-terminus, C-terminus, single cysteine residue, or handle-enabled chemistry (project-dependent). Conjugation strategies are selected to minimize heterogeneity while preserving peptide integrity, followed by purification and fit-for-purpose analytical confirmation aligned to research-stage and preclinical programs.
Competitive advantage: Unlike catalog GalNAc ligands, Bio-Synthesis provides custom GalNAc and Tri-GalNAc peptide conjugation services where ligand valency, attachment site, spacer/PEG length, and analytical strategy are selected to match your peptide sequence and research objective (project-dependent).
Bio-Synthesis service focus: Site-defined Tri-GalNAc peptide conjugation (mono vs multivalent; project-dependent), purification, and fit-for-purpose analytical confirmation (HPLC/UPLC; LC–MS when feasible) to support research-stage and preclinical workflows.
Explore related pages: peptide–targeting ligand conjugation services · non-drug peptide–ligand conjugates · peptide–imaging conjugates
GalNAc peptide conjugation is the covalent attachment of N-acetylgalactosamine (GalNAc) ligands to peptides to support ASGPR targeting, liver-focused delivery research, and hepatocyte uptake studies. Depending on the study goal, the peptide can be modified with a mono-GalNAc ligand or a clustered Tri-GalNAc / triantennary GalNAc ligand architecture.
These constructs are part of the broader peptide–targeting ligand conjugates workflow and can be combined with spacer/PEG design, imaging labels, or affinity handles when needed (project-dependent).
Last updated: February 2026
Evaluate receptor engagement, internalization kinetics, and hepatocyte uptake using GalNAc peptide conjugates.
Study the effect of ligand valency and spacing on ASGPR recognition using mono-GalNAc and Tri-GalNAc formats.
Non-clinical liver localization and targeting proof-of-concept studies (project-dependent).
Use this quick comparison to select the best GalNAc peptide conjugation format for your study. Final designs (valency, spacing, attachment site) are selected based on peptide sequence and assay requirements (project-dependent).
Jump to: supported formats · design considerations · workflow · request a quote
Triantennary presentation can increase apparent binding/uptake via multivalent interactions with ASGPR (context- and model-dependent). [1], [2]
ASGPR is predominantly expressed on hepatocytes and internalizes ligands via endocytosis—commonly leveraged in liver-targeting concepts. [2], [4]
Tri-GalNAc can be integrated with peptides, handles, and imaging tags (project-dependent), enabling modular workflows for research platforms. [3]
N-terminus, C-terminus, single-Cys, or handle-enabled strategies (project-dependent).
Spacer selection impacts accessibility of the GalNAc cluster and peptide function.
Mono vs triantennary formats and cluster geometry selected based on model (project-dependent).
Expand each section to see representative formats, typical applications, and notes. Final design depends on peptide sequence, desired valency, and assay requirements.
Tri-GalNAc formats present three GalNAc units in a clustered architecture to support multivalent receptor engagement concepts. Spacer choice and site-defined attachment can improve accessibility and reproducibility (project-dependent). [1], [2]
Related: Peptide–targeting ligand conjugates →
Mono-GalNAc formats are used when single-ligand presentation is needed (e.g., controls, mechanistic comparisons, or presentation studies). [2]
For visualization or platform capture, GalNAc–peptide constructs can be combined with imaging labels or affinity handles (project-dependent). Architecture is planned to preserve targeting ligand presentation and peptide function.
Related: Peptide–imaging conjugates → · Peptide–affinity tag conjugates →
Confirm peptide sequence(s), GalNAc format (mono vs Tri-GalNAc), attachment site, spacer needs, and assay (project-dependent).
Controlled conjugation using site-defined strategies to minimize heterogeneity.
Purification + fit-for-purpose analytical confirmation aligned to research needs.
Our GalNAc conjugation workflow starts with site selection and spacer planning, then proceeds through controlled coupling, purification, and analytical confirmation. Attachment can be planned at the N-terminus, C-terminus, single cysteine residue, or handle-enabled site to reduce heterogeneity while preserving peptide function (project-dependent).
Tri-GalNAc peptide conjugation is often combined with imaging labels, affinity handles, or other non-drug ligand conjugation services (project-dependent).
Broader non-drug targeting ligand conjugation options beyond GalNAc (project-dependent).
Learn more →
Add fluorescent labels for uptake and localization studies (project-dependent).
Explore fluorophore, affinity tag, vitamin/cofactor, glyco, and other non-drug peptide conjugates.
Bio-Synthesis follows controlled workflows and quality practices aligned with Total Quality Management (TQM). For Tri-GalNAc peptide conjugates, emphasis is placed on site-defined attachment, spacer selection, purification strategy, and fit-for-purpose analytical confirmation to support reproducible research outcomes.
Use “GalNAc peptide conjugates” as your primary SEO phrase because it captures broader search intent. Use “Tri-GalNAc” and “triantennary GalNAc” as secondary keywords for technical long-tail searches.
Tri-GalNAc is widely known from oligonucleotide delivery, but the underlying receptor-binding concept can also be evaluated in peptide conjugates for hepatocyte targeting research (project-dependent).
Yes. Spacer/PEG designs and optional imaging or affinity handles can be incorporated depending on the conjugation route and assay goals (project-dependent).
Provide peptide sequence(s), desired GalNAc format (mono vs triantennary), preferred attachment site/constraints, spacer preference, quantity/purity targets, and intended assay/biological model.
ASGPR targeting uses ligands such as GalNAc to support receptor-mediated recognition and uptake in hepatocyte-focused research models.
GalNAc is commonly used because ASGPR recognizes GalNAc-containing ligands and is strongly associated with hepatocyte uptake workflows.
GalNAc is generally used as a targeting ligand for ASGPR/hepatocyte uptake studies, while PEGylation is usually used as a spacer or solubility/handling modification. Some designs combine both.
“Triantennary” refers to a branched, three-arm ligand presentation (Tri-GalNAc) that displays multiple GalNAc units in one cluster to support multivalent ASGPR engagement concepts (project-dependent).
Common options include N-terminus, C-terminus, a single engineered cysteine, or handle-enabled chemistry. We typically recommend a site that preserves peptide activity while presenting GalNAc with minimal steric interference (project-dependent).
Many research designs use stable linkers/spacers to maintain ligand presentation. Cleavable linkers are evaluated only when a project specifically requires triggered release or remodeling of the architecture (project-dependent).
Yes. We can incorporate fluorophores or affinity handles (e.g., biotin) alongside GalNAc, with architecture planned to minimize interference between functions (project-dependent).
For the fastest quote on Tri-GalNAc / GalNAc–peptide conjugation services, share peptide sequence(s), desired GalNAc format (mono vs triantennary), preferred attachment site/constraints, spacer preference (if any), and quantity/purity targets.
References are provided for scientific background on ASGPR/GalNAc targeting and multivalent glycoconjugate concepts (for context; not clinical claims).
We support site-specific GalNAc attachment for peptide research projects using chemistry selected around the sequence, reactive handles, spacer requirements, and intended assay. References below are included to support the scientific background for GalNAc/ASGPR targeting and peptide conjugation design.
Trusted by biotech leaders worldwide for over 45+ years of delivering high quality, fast and scalable synthetic biology solutions.